Firm launches study of mitral regurgitation device

01/16/2013 | MassDevice.com (Boston)

Phoenix Cardiac Devices has begun patient enrollment in a clinical study of its Bace system, which is used to treat mitral regurgitation without the need for open-heart procedures. The trial, which will involve 60 patients from Europe and India, will be used to help the company obtain CE mark approval for the device in Europe.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC